A. Todisco et al., MOLECULAR MECHANISMS FOR SOMATOSTATIN INHIBITION OF C-FOS GENE-EXPRESSION, American journal of physiology: Gastrointestinal and liver physiology, 35(4), 1997, pp. 721-726
We reported previously that somatostatin inhibits the expression of th
e immediate early gene c-fos. Accordingly we characterized the molecul
ar mechanisms by which somatostatin inhibits c-fos gene expression. Be
cause growth factors activate c-fos through a region of its promoter k
nown as the serum response element [SRE; base pairs (bp) -357 to -276]
we transfected rat pituitary adenoma cells (GH(3)) with plasmids cont
aining the SRE or the SRE core fragment (bp -320 to -298) upstream of
the luciferase reporter gene. Epidermal growth factor (EGF) stimulated
SRE-luciferase activity, and this effect was inhibited by somatostati
n and by the analog MK-678. Identical results were obtained with the S
RE core plasmid, demonstrating that the sequence between bp -320 and -
298 of the c-fos promoter is a somatostatin response element. Because
the extracellular signal-regulated protein kinases (ERKs) induce the S
RE via phosphorylation of transcription factors such as Elk-1, we exam
ined the effect of somatostatin on ERK phosphorylation and activation.
EGF stimulated tyrosine phosphorylation of ERK2, and MK-678 attenuate
d this effect. In experiments using in-gel kinase assays, MK-678 also
inhibited EGF-stimulated ERK activity via a pertussis toxin sensitive
pathway, and this effect resulted in inhibition of Elk-1 transcription
al activity. Our data suggest that one mechanism of somatostatin actio
n involves inhibition of ERK activity, Elk-1 phosphorylation and trans
criptional activation, and ultimately c-fos gene transcription.